ACCUTIP.
LIVE

Serial Number

99380749

Owner

LTS Lohmann Therapie-Systeme AG

Attorney

Kirk M. Miles

Filing Date

Sep 8, 2025

Add to watchlist:

No watchlists yet
View on USPTO

ACCUTIP. Trademark

Serial Number: 99380749

ACCUTIP. is a trademark filed by LTS Lohmann Therapie-Systeme AG on September 8, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

LTS Lohmann Therapie-Systeme AG (10 trademarks)

Lohmannstrasse 2
Andernach 56626 , DE

Entity Type: 99

Trademark Details

Filing Date

September 8, 2025

Registration Date

Not Registered

Goods & Services

Apparatus and instruments for administering medicines, especially those including microneedles and/or microneedle arrangements or structures for use in the dermal, transdermal, mucosal and transmucosal administration of pharmaceuticals and biotechnological molecules; apparatus and instruments for administering medicines, especially those including microneedles and/or microneedle arrangements for use in the dermal, transdermal, mucosal and transmucosal sampling of body fluids; medical apparatus and instruments for administration of pharmaceuticals and biotechnological molecules using needle-shaped microstructures, including in the form of plasters to be used on the skin; injection instruments for pharmaceuticals; parts of the above goods, especially microneedles and/or microneedle arrangements, for use in the administration of pharmaceuticals and biotechnological molecules

Pharmaceutical and veterinary products; medical preparations; veterinary preparations; plasters; all of the above goods not for treating skin diseases; medical dressings

Medical consulting of patients and specialist staff, especially physicians, with respect to systems and instruments for administering medicines, especially those including microneedles and/or microneedle arrangements or structures for use in the dermal, transdermal, mucosal and transmucosal administration of pharmaceuticals and biotechnological molecules; formulation and administration of medicines, including through plasters for use on the skin

Filing History

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
May 12, 2026 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
May 12, 2026 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 12, 2026 GNRN
NON-FINAL ACTION E-MAILED
Feb 12, 2026 GNRT
NON-FINAL ACTION WRITTEN
Feb 12, 2026 CNRT
ASSIGNED TO EXAMINER
Dec 12, 2025 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Dec 9, 2025 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 9, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Sep 8, 2025 MAFR
NEW APPLICATION ENTERED
Sep 8, 2025 NWAP